Document is current

Any future updates will be listed below

Correction: The financial burden of vancomycin as an alternative to cefazolin for periprosthetic joint infection prophylaxis in total knee arthroplasty

Crossref DOI link: https://doi.org/10.1007/s00402-025-05985-8

Published Online: 2025-08-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark